Printed from the IBC Life Sciences Web site on May 25, 2015 7:13 AM ET.
Page location: http://www.ibclifesciences.com/TIDES/advisors.xml
May 03-06, 2015 Town and Country ResortSan Diego, CA
Kathryn L. Ackley, Ph.D., RAC, Senior Director Cincinnati Operations, Nitto Denko Avecia Inc.
Firoz Antia, Ph.D., CMC Team Director, Pharmaceutical Operations and Technology, Biogen Idec
Mimoun Ayoub, Ph.D., Director, Global Peptides and Injectables, Corden Pharma, Switzerland
Neil H. Baine, Ph.D., President, Neil Baine Consulting, LLC and Past Executive Director, Scinovo, Preclinical Development, GlaxoSmithKline Pharmaceuticals
Doug Brooks, Ph.D., Vice President, Manufacturing Development, Ophthotech Corporation
Bob D. Brown, Ph.D., Chief Scientific Officer and Senior Vice President, Research, Dicerna Pharmaceuticals
David Brown, Ph.D., Director, Discovery and in vivo Research, Mirna Therapeutics, Inc.
Jesse Dong, Ph.D., Founder, Amphitide
Alex Fässler, Ph.D., COO Europe, Bachem AG, Switzerland
Elena Feinstein, M.D., Ph.D., Chief Scientific Officer, Quark Pharmaceuticals, Israel
Chris Holmes, Ph.D., Former Vice President, Chemical and Pharmaceutical Development, Regado Biosciences
Peter Hoffmann, Ph.D.
Troels Koch, Ph.D., Vice President, Research and CTO, Roche Innovation Center Copenhagen, Denmark
David Litzinger, Ph.D., President, David Litzinger and Associates, LLC
John P. Mayer, Ph.D., Senior Research Scientist, Department of Chemistry, Indiana University
Muthiah (Mano) Manoharan, Ph.D., Senior Vice President of Drug Discovery, Alnylam Pharmaceuticals, Inc.
Paul McCormac, Ph.D., Director, Biomanufacturing Sciences Group, Pfizer Global Manufacturing
Michael McGinley, Senior Product Manager- BioSeparations, Phenomenex
Bruce Morimoto, Ph.D., Executive Director Applied Translational Medicine, Drug Development Services, Celerion
Gary F. Musso, Ph.D., President, Musso and Associates LLC
Lubomir V. Nechev, Ph.D., Vice President, Process Sciences, Alnylam Pharmaceuticals, Inc.
Pamela Pavco, Ph.D., Chief Development Officer, RXi Pharmaceuticals
El Djouhar Rekaï, Head of Peptide Products Operation, Lonza, Belgium
Claus Rentel, Ph.D., Executive Director, Analytical Development/Quality Control, Isis Pharmaceuticals
Christopher A. Rhodes, Ph.D., President and CEO, Drug Delivery Experts
Christoph Rosenbohm, Ph.D., Senior Director, Research Operations, Roche Innovation Center Copenhagen, Denmark
Tomi Sawyer, Ph.D., Distinguished Scientist & Head, Peptide Drug Discovery and Innovative Technologies, Merck Research Laboratories
Trishul Shah, Associate Director, Business Development, North America, PolyPeptide Laboratories
Ved Srivastava, Ph.D. Head of Peptide Chemistry, GlaxoSmithKline
G. Susan Srivatsa, Ph.D., President, ElixinPharma
James D. Thompson, Ph.D., Head, CMC and Analytical Development, Moderna Therapeutics, Inc.
Peter Timmerman, Ph.D., Chief Scientific Officer, Pepscan Therapeutics, The Netherlands
Blake Unterreiner, Business Development Manager, Nucleic Acid Solutions Division, Agilent Technologies, Inc.
Thomas Vorherr, Ph.D., Director Peptide Discovery, Novartis Pharma AG, Switzerland
Paul Watt, Ph.D., Chief Scientific Officer, Phylogica Ltd., Australia
Fran Wincott, Ph.D., President, Wincott & Associates, LLC